Skip to main content

Table 3 Laboratory Data

From: Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation

 

DM (n = 149)

Non-DM (n = 188)

p value

At the time of PCI

 HbA1c, %

7.1 ± 1.2

5.8 ± 0.5

< 0.001

 FBS, mg/dL

156 ± 60

110 ± 30

< 0.001

 Total cholesterol, mg/dL

176 ± 39

180 ± 38

0.25

 Triglyceride, mg/dL

169 ± 109

133 ± 100

0.002

 HDL-cholesterol, mg/dL

44 ± 13

50 ± 14

< 0.001

 LDL-cholesterol, mg/dL

103 ± 32

105 ± 34

0.58

 CRP, mg/dL

0.42 ± 1.04

0.71 ± 2.53

0.17

 Hemoglobin, g/dL

13.5 ± 2.1

13.7 ± 1.7

0.45

 Creatinine, mg/dL

1.2 ± 1.9

1.1 ± 1.1

0.31

 eGFR, mL/min/m2

65 ± 21

64 ± 18

0.39

 Uric acid, mg/dL

5.6 ± 1.5

5.9 ± 1.5

0.052

At the time of CAS evaluation

 HbA1c, %

6.8 ± 0.8

5.7 ± 0.5

< 0.001

 FBS, mg/dL

146 ± 55

107 ± 21

< 0.001

 Total cholesterol, mg/dL

162 ± 35

170 ± 31

0.036

 Triglyceride, mg/dL

151 ± 112

141 ± 100

0.36

 HDL-cholesterol, mg/dL

47 ± 18

50 ± 13

0.057

 LDL-cholesterol, mg/dL

90 ± 26

92 ± 25

0.46

 CRP, mg/dL

0.24 ± 0.52

0.32 ± 1.25

0.49

 Hemoglobin, g/dL

13.2 ± 1.9

13.6 ± 1.6

0.036

 Creatinine, mg/dL

1.5 ± 3.8

1.1 ± 0.9

0.19

 eGFR, mL/min/m2

64 ± 18

60 ± 17

0.14

 Uric acid, mg/dL

5.6 ± 1.5

5.9 ± 1.5

0.073

  1. Data are presented as mean ± SD
  2. CAS  coronary angiography, CRP   C-reactive protein, DM diabetes mellitus, eGFR  estimated glomerular filtration rate, FBS fasting blood sugar, HbA1c  Hemoglobin A1c, HDL high-density lipoprotein, LDL  low-density lipoprotein